Please join us for the latest installment of Cooley Talks Life Sciences. In this quarterly virtual series, we tap into Cooley’s unrivaled network of life sciences thought leaders to discuss key industry developments, challenges, solutions and the road ahead.
At Cooley, we don’t just advise – we accelerate your achievements.
In this episode, our panel will unpack how life sciences companies can make the most of their J.P. Morgan Healthcare Conference (JPM) experience. We’ll explore how to build momentum, boost visibility and position your company for meaningful engagement at one of the industry’s most influential events of the year. Plus, our team will break down the current market landscape to help you navigate JPM with confidence and clarity.
Key topics will include:
- Decoding the current market landscape: Investor sentiment, deal flow and valuation dynamics shaping the life sciences sector.
- Telling your story: Crafting an investor narrative that resonates and attracts capital.
- Making every meeting count: How to create a schedule of high-value meetings and prepare a deck that leaves potential investors, partners or acquirers wanting to hear more.
- Amplifying your presence: Elevating your brand at JPM through media, thought leadership and networking events.
Panelists
- Chris Brinzey – Partner and Head of Life Sciences practice at ICR Healthcare
- Mike Connor – Managing Director of biopharma investment banking at J.P. Morgan
- Susan Molineaux, PhD – CEO at Para Therapeutics
- Rama Padmanabhan – Partner at Cooley
- Charity Williams – Partner at Cooley
- Courtney Thorne (moderator) – Partner at Cooley